Human papillomavirus vaccination in men who have sex with men - what will be required by 2020 for the same dramatic changes seen in heterosexuals
Christopher K Fairley, Huachun Zou, Lei Zhang, Eric PF Chow
SEXUAL HEALTH | CSIRO PUBLISHING | Published : 2017
This paper addresses the issue of whether men who have sex with men (MSM) will share the spectacular reductions in human papillomavirus (HPV) infection and its associated neoplasia that we are currently witnessing in heterosexuals. The reproductive rate for HPV infection in heterosexuals is not well established, but 70% vaccination coverage in women has resulted in a fall of more than 90% in genital warts and HPV types 16/18 in young women and 80% fall in young men indicating that the critical vaccination threshold has been exceeded for this group. Published data on the three elements of the reproductive rate for HPV infection (i.e. transmission probability per sexual partnership, rate of pa..View full abstract
CKF owns shares in CSL Biotherapies that market Gardasil in Australia. EPFC has received educational grant for HPV research from CSL Biotherapies to attend the 30th International Papillomavirus Conference (HPV 2015) and Seqirus to attend the EUORGIN 2016 Conference.